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S U M M A R Y
Objectives: To study the prevalence, risk factors, and genotypes of drug-resistant Mycobacterium
tuberculosis in Karachi.
Methods: Pulmonary tuberculosis (TB) patients were recruited in a cross-sectional study (2006–2009).
Drug susceptibility testing was performed for culture-positive cases (n = 1004). Factors associated with
drug resistance were evaluated using logistic regression analysis. Strains were typed using spoligotyping
and mycobacterial interspersed repetitive units–variable number tandem repeat (MIRU–VNTR). The
associations of genotype and drug resistance were explored using the Chi-square test.
Results: Resistance rates – new and previously treated – were as follows: multidrug-resistant (MDR)-TB,
2.4% and 13.9%, respectively; rifampin (RIF) monoresistance, 0.1% and 0.6%, respectively; any isoniazid
(INH) resistance, 8.9% and 28.5%, respectively; and INH monoresistance, 3.0% and 6.3%, respectively. Prior
TB treatment was a risk factor for MDR-TB (adjusted odds ratio (AOR) 6.8, 95% conﬁdence interval (CI) 3.5–
13.1) and INH monoresistance (AOR 2.4, 95% CI 1.1–5.2). Additional risk factors included low
socioeconomic status for INH monoresistance (AOR 3.3, 95% CI 1.7–6.5), and belonging to Balouchi
(AOR 9.2, 95% CI 2.5–33.4), Sindhi (AOR 4.1, 95% CI 1.2–13.5), or Pakhtun (AOR 3.4, 95% CI 1.0–11.2)
ethnicity for MDR-TB. Although Central Asian strain (55.6%) was the most prevalent genotype, MDR-TB was
signiﬁcantly associated with Haarlem (H) genogroup (crude OR 9.2, 95% CI 3.6–23.8).
Conclusions: An MDR-TB rate of 2.4% is reported in new patients. Low RIF monoresistance supports the
use of RIF as a marker for MDR-TB in this population. The need to strengthen TB care in the identiﬁed at-
risk groups is emphasized. Based on INH resistance rates, a review of national treatment/prevention
regimens relying on INH is suggested.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Emerging drug resistance poses a serious threat to the control of
tuberculosis (TB), which remains a leading infectious cause of death
worldwide.1,2 The World Health Organization (WHO) estimated
440 000 (95% conﬁdence interval (CI) 390 000–510 000) cases of
multidrug-resistant (MDR)-TB globally in 2008 (3.6% of all incident
TB cases), causing an estimated 150 000 deaths.3 Pakistan ranks
eighth on the list of 27 high MDR-TB burden countries, with
an estimated 15 000 cases occurring in 2008 (2.9% in untreated
and 35.4% in treated patients).4 A hospital-based study from
Pakistan reported an MDR-TB prevalence of 1.8% amongst untreated
TB patients.5 In the absence of a national prevalence survey,* Corresponding author. Tel.: +92 21 34861640/34861641;
fax: +92 21 34934294.
E-mail address: rumina.hasan@aku.edu (R. Hasan).
1201-9712/$36.00 – see front matter  2012 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.12.015information from community-based studies is required to help
estimate the burden of MDR-TB in the country. Globally, resistance
to isoniazid (overall) is estimated at 13.3% (10.3% in new and 27.7% in
treated patients).6 Resistance to isoniazid (INH) has also been
reported from neighboring India (11% in new and 37% in treated
patients)7 and Bangladesh (23% in new patients).8 A three-drug
regimen, i.e., INH, rifampin (RIF), and ethambutol (EMB), is
recommended during the continuation phase for new TB patients
in populations with high levels of INH resistance.9 In view of limited
local information on INH resistance in untreated patients, the
national guidelines in Pakistan currently advocate INH and RIF
during the continuation phase.10However, local INH resistance data
are essential for the selection of an appropriate regimen for such
patients. This information will also help in deciding the role of INH
prophylactic therapy for patients with latent TB in this area.
Over the last 10 years, molecular typing of Mycobacterium
tuberculosis (MTB) has emerged as an important tool for estimatingses. Published by Elsevier Ltd. All rights reserved.
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typing) of MTB strains from Pakistan has shown a heterogeneous
population structure, with a predominance of the Central Asian
Strain (CAS) genotype.12–14 An association between MDR-TB and
Beijing strains has also been reported from the country.12,13 These
studies have established the baseline diversity and population
structure of MTB isolates from Pakistan. Given a population of over
160 million, an expansive and diverse terrain, and multiple ethnic
groups, there is a need to study strains from deﬁned geographic
areas within Pakistan.
An earlier interim analysis of this study reported the prevalence
of and risk factors associated with MDR-TB.15 These were
reassessed in light of this completed study and a larger sample
size. Moreover, the prevalence of INH resistance and risk factors for
INH-monoresistant TB were determined. Prevalent MTB genotypes
and their associations with drug resistance were also investigated.
2. Methods
This was a cross-sectional study conducted in Karachi from July
2006 to September 2009. Karachi is the economic hub and largest
city of Pakistan, with a population of around 17 million. It is divided
into 18 administrative units.16 The study subjects were recruited
from 10 ﬁeld clinics run by the Marie Adelaide Leprosy Centre
(MALC) located in 10 of the 18 administrative units of Karachi, as
previously described.15These clinics are accessible to the population
from across the city, including individuals from the low to middle
socioeconomic groups. They provide care to a mixed population
representing all the major ethnic groups of the city. The clinic
patients are either self-referred or are referred by their general
practitioners. All patients presenting to the clinics with a clinical
suspicion of pulmonary TB during the study period and who
consented to participation were recruited into the study and
interviewed on their initial visit. A pre-tested structured question-
naire was administered to glean information on socio-demographic
and other characteristics. Early morning sputum specimens were
collected for smear examination, culture, and drug susceptibility
testing.
Drug susceptibility was tested by agar proportion method on
enriched Middlebrook 7H10 medium (BBL) using the following
drug concentrations: RIF 1 mg/ml and 5 mg/ml, INH 0.2 mg/ml and
1 mg/ml, streptomycin (STR) 2 mg/ml and 10 mg/ml, EMB 5 mg/ml
and 10 mg/ml, oﬂoxacin 1 mg/ml, amikacin 6 mg/ml, kanamycin
6 mg/ml, and capreomycin 10 mg/m. Pyrazinamide (PZA) sensitivity
testing was carried out using the BACTEC 7H12 medium pH 6.0 at
100 g/ml (BACTECTM PZA Test Medium, Becton Dickinson, USA);
MTB H37Rv was used as control with each batch of susceptibility
testing. Resistance to RIF 1 mg/ml, INH 0.2 mg/ml, STR 2 mg/ml, and
EMB 5 mg/ml was used as the cut-off for this study. MDR-TB was
deﬁned as a TB isolate resistant to at least INH and RIF.3 Extensively
drug-resistant (XDR)-TB was deﬁned as MDR isolates with
additional resistance to a ﬂuoroquinolone (oﬂoxacin) and to
any one of the second-line injectable anti-TB drugs (amikacin,
capreomycin, or kanamycin).3
2.1. Genotyping methods
2.1.1. Spoligotyping
Culture-positive isolates were typed by spoligotyping using a
commercially available kit (Isogen Bioscience BV, Maarssen, the
Netherlands).17 Results were analyzed using BioNumerics soft-
ware (BioSystematica, UK). Dendrograms were generated using the
unweighted pair group method with arithmetic averages (UPGMA)
calculation. The spoligotypes were compared with the most
prevalent MTB subfamilies as identiﬁed by the World Spoligotyp-
ing Database SpolDB4.0 of the Pasteur Institute, Guadeloupe.182.1.2. Mycobacterial interspersed repetitive unit–variable number
tandem repeat (MIRU-VNTR) typing
MDR-TB isolates were further genotyped by PCR ampliﬁcation
of the 15 MIRU-VNTR loci, as previously described by Supply
et al.19 PCRs were carried out using 40–60 ng of DNA per reaction in
25 ml volume using 0.4 mM speciﬁc primers, 0.5 mM dNTPs mix,
1 mM MgCl2, 1 PCR buffer, 4% dimethyl sulfoxide (DMSO), and
1 U of Super Tth Taq DNA polymerase. PCR was performed as
follows: 15 min at 95 8C, 35 cycles, 1 min at 94 8C, 1 min at 59 8C,
1 min 30 s at 72 8C, 10 min at 72 8C. The PCR products were
electrophoresed on a 3% agarose gel and sized with a 100-bp ladder
(Promega). All the reactions were performed in duplicate using
standard positive and negative controls supplied with the MIRU-
VNTR validation kit. Sizing of the PCR fragments and assignment of
the various VNTR alleles were also done using the standard
protocol (Philip Supply INSERM U629, Institut de Biologie/Institut
Pasteur de Lille; May 2005; http://www.genoscreen.com). Results
of the MIRU-VNTR typing were analyzed using BioNumerics
software (BioSystematica, UK).
2.2. Data analysis
Data were double-entered in EpiData and compared for errors.
Analysis was done on 1004 culture-positive specimens using SPSS
version 19 (IBM SPSS, Chicago, IL, USA). Descriptive statistics were
computed for all variables. Means ( standard deviation) were
calculated for continuous variables, while frequencies with percen-
tages were calculated for categorical variables.
The prevalence of MDR-TB and INH-resistant TB with 95% CI
was calculated. Socio-demographic and other factors associated
with MDR-TB and INH- monoresistant TB were evaluated using
the Chi-square test of independence. Adjusted odds ratios (AOR)
and their 95% CI were estimated using logistic regression
analysis.
Patients with MDR and INH-monoresistant MTB were compared
to patients with drug-susceptible MTB strains. Individuals with
resistance patterns other than MDR and INH-monoresistant TB were
excluded from the analysis. Variables with a p-value of <0.25 in the
univariate analysis were considered for multivariable analysis. The
ﬁnal model was constructed after checking for confounding and
interaction. Model adequacy checks were performed. Variables with
a p-value of <0.05 were retained in the ﬁnal model. INH-
monoresistant TB was deﬁned as resistance to only INH.
Some independent variables were re-coded into meaningful
categories, while a few new variables were developed. A variable
for crowding index was constructed by dividing the number of
individuals per household by the number of bedrooms. A
participant’s household crowding was deﬁned as ‘low’ if they
scored an index of 0–1.9, moderate if 2–3.9, and high if 4. Another
variable termed socioeconomic status was constructed based on
the possession of household commodities in accordance with the
National Health Survey of Pakistan 1990–1994 criteria. Ethnicity
was assessed using mother tongue as the proxy variable.
The association of strain types and drug resistance was explored
using the Chi-square test of independence. Crude odds ratios (COR)
were calculated for signiﬁcant associations found.
3. Results
3.1. Study population
A total of 1229 subjects with a clinical suspicion of pulmonary
TB were recruited. Specimens from 16 cases grew Mycobacterium
species other than MTB, while 209 samples were culture-negative.
These 225 samples were excluded from the analysis. MTB culture-
positive patients (n = 1004) were studied. The mean age of the
Table 1
Characteristics of Mycobacterium tuberculosis culture-positive subjects: comparison of patients with multidrug-resistant and isoniazid-monoresistant M. tuberculosis with
drug-susceptible M. tuberculosis patients
Characteristic Total
(N = 1004), n (%)
Fully drug susceptible
(n = 770), n (%)
MDR
(n = 43), n (%)
p-Value INH- monoresistant
(n = 35), n (%)
p-Value
Age mean ( SD) 32.3 ( 15.5) 33 ( 16) 34 ( 13) 32 ( 16)
Age group, years
9–14 32 (3.2) 22 (2.9) 2 (4.7) 1 (2.9)
15–29 521 (51.9) 409 (53.1) 16 (37.2) 0.167 19 (54.3) 0.907
30–44 209 (20.8) 148 (19.2) 13 (30.2) 8 (22.9)
45 242 (24.1) 191 (24.8) 12 (27.9) 7 (20)
Gender
Male 531 (52.9) 415 (53.9) 18 (41.9) 0.124 20 (57.1) 0.706
Female 473 (47.1) 355 (46.1) 25 (58.1) 15 (42.9)
Marital status
Single 443 (44.1) 351 (45.6) 10 (23.3) 0.004 15 (42.9) 0.751
Married 561 (55.9) 419 (54.4) 33 (76.7) 20 (57.1)
Ethnicity
Urdu-speaking 296 (29.5) 239 (31.0) 9 (20.9) 0.001 5 (14.3) 0.269
Punjabi 233 (23.2) 182 (23.6) 5 (11.6) 7 (20)
Pakhtun 149 (14.8) 104 (13.5) 8 (18.6) 6 (17.1)
Sindhi 108 (10.8) 81 (10.5) 8 (18.6) 7 (20)
Balouchi 47 (4.7) 29 (3.8) 7 (16.3) 1 (2.9)
Othera 171 (17.0) 135 (17.5) 6 (14.0) 9 (25.7)
Education
Literateb 475 (47.3) 379 (49.2) 13 (30.2) 0.018 11 (31.4) 0.039
Non-literate 529 (52.7) 391 (50.8) 30 (69.8) 24 (68.6)
Employment status
Employed 296 (29.5) 223 (29.0) 12 (27.9) 0.882 14 (40) 0.161
Unemployed 708 (70.5) 547 (71.0) 31 (72.1) 21 (60)
Household income,c rupees/month
5000 412 (48.3) 294 (45.0) 24 (68.6) 0.006 23 (69.7) 0.005
>5000 441 (51.7) 360 (55.0) 11 (31.4) 10 (30.3)
Socioeconomic statusd
Upper 14 (1.4) 13 (1.7) 1 (2.4) 0.002 0 0.001
Middle 659 (67.7) 522 (69.9) 18 (42.9) 16 (45.7)
Lower 300 (30.8) 212 (28.4) 23 (54.8) 19 (54.3)
Crowding indexe
4 (high) 440 (45.2) 324 (43.3) 24 (57.1) 0.079 19 (54.3) 0.201
0–3.9 (low/moderate) 534 (54.8) 424 (56.7) 18 (42.9) 16 (45.7)
Contact exposure present 284 (28.3) 225 (29.2) 8 (18.6) 0.166 9 (25.7) 0.655
BCG scar present 412 (41.0) 316 (41.0) 16 (37.2) 0.637 13 (37.1) 0.642
Previous history of TB present 158 (15.7) 104 (13.5) 22 (51.2) <0.001 10 (28.6) 0.012
MDR, multidrug-resistant; INH, isoniazid; SD, standard deviation; BCG, bacille Calmette–Gue´rin; TB, tuberculosis.
a Other includes: Hindko, Saraiki, Bangali, Hindu, Persian, etc.
b Literate is deﬁned as the ability of the individual to read.
c n = 151 (15%) missing values.
d n = 31 (3.1%) missing values.
e n = 30 (3.0%) missing values.
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were males. Both literacy and employment rates were higher
amongst males (50.7% and 51.6%, respectively) than females (43.6%
and 4.7%, respectively). Five major ethnic groups were identiﬁed:
Urdu-speaking (29.5%), Punjabi (23.2%), Pakhtun (14.8%), Sindhi
(10.8%), Balouchi (4.7%), and others (17.0%). A bacille Calmette–
Gue´rin (BCG) scar was present in 412 (41.0%) patients, while 284
(28.3%) gave a history of contact with a TB patient. Overall 158 (15.7%)
patients had previously been treated for TB (Table 1).
3.2. Drug resistance
Resistance to one or more of the ﬁve ﬁrst-line anti-TB drugs was
noted in 23.3% (n = 234) of patients. The INH resistance rate was
12.0% (95% CI 10.0–14.0%); 8.9% in untreated and 28.5% in treated
patients. Resistance to other ﬁrst-line drugs was as follows: STR
16.6%, PZA 6.5%, EMB 4.7%, and RIF 4.6%. The overall MDR-TB rate
was 4.3% (95% CI 3.1–5.5%); 2.5% in untreated and 13.9% in treated
patients (Table 2). All MDR-TB isolates (n = 43) were also resistant
to PZA, 32 (74.4%) to EMB, and 23 (53.5%) to STR. No XDR-TB
isolates were detected, although ﬁve isolates among the MDR-TB
group were also resistant to oﬂoxacin.RIF monoresistance was seen in only 0.2% of cases. INH
resistance other than MDR was 7.7% (n = 77); 6.5% in untreated and
14.5% in treated cases. These included 35 (3.5%) INH-monoresis-
tant and 42 (4.2%) polyresistant cases (Table 2).
3.3. Factors associated with drug resistance
3.3.1. Factors associated with MDR-TB
MDR-TB patients (n = 43) were compared to patients with
drug-susceptible MTB strains (n = 770). Univariate analysis
revealed a higher proportion of females (p = 0.124), married
persons (p = 0.004), and individuals aged more than 27 years
(p = 0.036) amongst MDR-TB patients. MDR patients were more
likely to be non-literate (p = 0.018), have a lower income
(p = 0.006), and belong to the lower socioeconomic status group
(p = 0.002). A higher proportion of MDR-TB patients reported
living in overcrowded houses (p = 0.079) (Table 3). The ﬁnal
multivariable logistic regression model identiﬁed prior history
of TB treatment (AOR 6.8, 95% CI 3.5–13.1), being married
(AOR 2.7, 95% CI 1.3–5.6), and belonging to Balouchi (AOR 9.2,
95% CI 2.5–33.4), Sindhi (AOR 4.1, 95% CI 1.2–13.5), and
Pakhtun (AOR 3.4, 95% CI 1.0–11.2) ethnic groups to be associated
Table 2
Pattern of drug resistance in study isolates
New cases Previously treated cases Combined
n % n % n %
Number of strains tested 846 100 158 100 1004 100
Strain susceptibility/resistance
Susceptible to all 5 drugs 666 78.7 104 65.8 770 76.7
Resistant to 1 drug 128 15.1 19 12.0 147 14.6
Resistant to 2 drugs 18 2.1 6 3.8 24 2.4
Resistant to 3 drugs 14 1.7 9 5.7 23 2.3
Resistant to 4 drugs 10 1.2 9 5.7 19 1.9
Resistant to 5 drugs 10 1.2 11 7.0 21 2.1
Any resistance 180 21.3 54 34.2 234 23.3
Isoniazid (INH) 75 8.9 45 28.5 120 12.0
Rifampin (RIF) 23 2.7 23 14.6 46 4.6
Pyrazinamide (PZA) 35 4.1 30 19.0 65 6.5
Ethambutol (EMB) 27 3.2 20 12.7 47 4.7
Streptomycin (STR) 136 16.1 31 19.6 167 16.6
Monoresistant 128 15.1 19 12.0 147 14.6
Isoniazid (INH) 25 3.0 10 6.3 35 3.5
Rifampin (RIF) 1 0.1 1 0.6 2 0.2
Pyrazinamide (PZA) 1 0.1 0 0 1 0.1
Ethambutol (EMB) 3 0.4 1 0.6 4 0.4
Streptomycin (STR) 98 11.6 7 4.4 105 10.5
Multidrug-resistant 21 2.5 22 13.9 43 4.3
INH + RIF + PZA 4 0.5 5 3.2 9 0.9
INH + RIF + PZA + EMB 6 0.7 5 3.2 11 1.1
INH + RIF + PZA + STR 1 0.1 1 0.6 2 0.2
INH + RIF + PZA + EMB + STR 10 1.2 11 7.0 21 2.1
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(Table 3).
3.3.2. Factors associated with INH-monoresistant TB
Comparison of patients with INH-monoresistant (n = 35) and
drug-susceptible MTB strains (n = 770) using univariate analysisTable 3
Logistic regression analysis of factors associated with multidrug-resistant tuberculosis
Characteristic Crude ORa (95% CI) 
Ageb
>27 years 1.966 (1.034–3.740)
Gender
Female 1.624 (0.871–3.025)
Marital status
Married 2.764 (1.343–5.688) 
Ethnicity 
Punjabi Reference
Sindhi 3.595 (1.141–11.327) 
Pakhtun 2.8 (0.893– 8.782) 
Urdu-speaking 1.371 (0.452–4.160) 
Balouchi 8.786 (2.613–29.544) 
Socioeconomic statusc
Upper/middle Reference
Lower 3.035 (1.620–5.687)
Education
Non-literate 2.237 (1.149–4.354)
Monthly income
5000 rupees/month 2.672 (1.287–5.544)
Crowding index
Low/moderate Reference
High 1.745 (0.931–3.270)
Household exposure
Present 0.554 (0.253–1.212)
Previous history of TB
Present 6.709 (3.564–12.630) 
OR, odds ratio; CI, conﬁdence interval; TB, tuberculosis.
a Signiﬁcance level 0.05.
b Age is dichotomized at median after scale examination.
c Socioeconomic status categories are based on National Health Survey of Pakistan (showed that INH-monoresistant TB patients included a higher
proportion of individuals who were non-literate (p = 0.039), had a
lower income (p = 0.005), and a lower socioeconomic status
(p = 0.001). A higher proportion of INH-monoresistant TB patients
lived in overcrowded houses (p = 0.201) (Table 4). After adjusting
for other variables, the ﬁnal multivariable logistic regressionAdjusted OR (95% CI) p-Valuea
2.655 (1.253–5.627) 0.011
0.007
4.104 (1.244–13.539) 0.020
3.424 (1.048–11.186) 0.042
1.606 (0.514–5.016) 0.415
9.184 (2.523–33.432) 0.001
6.797 (3.516–13.139) <0.001
1990–1994).
Table 4
Logistic regression analysis of factors associated with INH-monoresistant TB
Characteristics Crude OR (95% CI) Adjusted OR (95% CI) p-Valuea
Socioeconomic statusb
Upper/middle Reference
Lower 3.435 (1.733–6.808) 3.289 (1.653–6.545) 0.001
Education
Illiterate 2.115 (1.022–4.378)
Employment status
Unemployed 0.612 (0.306–1.224)
Monthly income
5000 rupees/month 2.816 (1.319–6.011)
Crowding index
Low/moderate Reference
High 1.554 (0.787–3.069)
Previous history of TB
Yes 2.562 (1.196–5.488) 2.408 (1.110–5.224) 0.026
OR, odds ratio; CI, conﬁdence interval; TB, tuberculosis.
a Signiﬁcance level 0.05.
b Socioeconomic status categories are based on National Health Survey of Pakistan (1990–1994).
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5.2) and lower socioeconomic status (AOR 3.3, 95% CI 1.7–6.5) to be
associated with INH-monoresistant TB (Table 4).
3.4. Genotypic pattern of MTB isolates
Of the 1004 isolates, 987 were spoligotyped. The remaining
17 samples either did not grow or were contaminated. The most
prevalent genogroup was CAS (55.6%), followed by the East AfricanFigure 1. MIRU-VNTR pattern of multidrug-resistant Mycobacterium tuberculosis isolate
MIRU-VNTR typing. These comprised Beijing (n = 2), CAS (n = 1), CAS1_Delhi (n = 19),
spoligotypes. A composite dendrogram of M. tuberculosis spoligotypes and MIRU-VNTR
amongst ‘H’ and ‘unique’ strains are indicated as MDR-C1 and MRD-C2.Indian (EAI) (9.6%), T clade (4.9%), Haarlem (H) (3.1%), Beijing
(2.7%), U clade (2.5%), MANU (0.2%), Lam American Mediterranean
(LAM) (0.4%), X (0.2%), orphan clusters (6.9%), and unique isolates
(13.5%) (see Supplementary Material Figure S1 and Table S1).
Amongst the MDR isolates (n = 41), prevalent genogroups
observed were CAS1_Delhi (46.3%), CAS (2.4%), H1 (2.4%),
H4 (19.5%), Beijing (4.9%), LAM (4.9%), T3 (2.4%), and U (2.4%), in
addition to unique strains (14.6%) (Figure 1). H strains were found to
be signiﬁcantly higher amongst the MDR-TB group (COR 9.2, 95% CIs. Forty-one multidrug-resistant M. tuberculosis isolates were subjected to 15 loci
 H1 (n = 1), H4 (n = 8), LAM9 (n = 2), T3 (n = 1), U458 (n = 1), and unique (n = 6)
 types was created using BioNumerics software. Two separate clusters identiﬁed
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TB strains to investigate further the clustering between isolates. One
cluster of two strains was found in H genogroup (H4; MDR-C1),
while an additional cluster of two strains was observed between two
unique MIRU types (MDR-C2) (Figure 1).
INH-monoresistant isolates included 58.8% CAS and 20.6% EAI
genogroup, while STR-monoresistant isolates included 58.7% CAS,
8.7% EAI, and 7.7% T strains. However, in both cases no signiﬁcant
association with any speciﬁc genotype was seen.
4. Discussion
This study reports the prevalence, risk factors, and genotypes of
drug-resistant M. tuberculosis in Karachi, a city with a population of
over 17 million. The MDR-TB rate of 2.4% amongst untreated
patients is compatible with the earlier interim analysis showing
2.3% MDR in such patients.15 These results are consistent with a
previous study reporting 1.8% MDR amongst new TB patients in
Pakistan.5 The diagnosis of MDR-TB has been greatly facilitated by
the recently launched GeneXpert, which relies on RIF resistance as
a marker to detect MDR-TB.20 The fact that 99.9% of RIF-resistant
new patients in this study were also MDR, augers well for the
performance of GeneXpert. However, the INH resistance rate of
8.9% amongst new patients (12.0% overall) reported in this study is
concerning. The ﬁndings suggest that using only INH and RIF
during the continuation phase for new patients may well lead to an
increase in MDR-TB. Such information becomes more relevant
given that the detection of INH resistance is difﬁcult in this
population where 15% of all new TB cases are extrapulmonary2 and
where there is a considerable disease burden in children.21 The
data further suggest that the role of INH prophylaxis in the area
requires review.
The ﬁnding of high resistance to STR among the ﬁrst-line anti-
TB drugs is consistent with data from other countries,22–24 and
highlights the importance of susceptibility testing in cases where
STR use is planned.
The association of multidrug resistance with Sindhi and
Pakhtun ethnic groups reported in the interim analysis15 is
conﬁrmed. Using a larger sample size we further found an
association with the Balouchi ethnic group that was not detected
previously. However, INH monoresistance (which was not
explored in the earlier analysis) did not appear to be related to
ethnicity, but only to low socioeconomic status. It is likely that
limited health access in these marginalized at-risk populations
plays a role in the development of MDR-TB. The data from the
current study using a larger sample size did not conﬁrm the
association of MDR-TB with female sex, which was reported in the
interim analysis. The association between MDR-TB and married
individuals is likely to be age-related, the highest frequency of
MDR-TB cases being in the 28–42 years age group, thus including a
signiﬁcant proportion of married individuals. This ﬁnding is
consistent with data from China and Europe also reporting a
higher risk of MDR-TB in the 35–44 years age group.22,25
Genotyping results support earlier reports of a predominance of
CAS genogroup, particularly CAS1_Delhi, which appears to play a
signiﬁcant role in disease transmission in this area, together with
other clusters – Beijing, EAI, and Haarlem.12–14 Previous studies
from Pakistan have suggested an association between Beijing
strains and MDR.12,13 In this study, however, we observed a
signiﬁcantly higher proportion of H strains amongst MDR isolates.
Our data thus highlight the need to analyze strain populations
from different geographic locations within the country in order to
better understand the transmission dynamics of MTB. The high
frequency of H strains amongst MDR-TB patients has also been
reported from Afghanistan and Iran.26 Cross-border trafﬁc
between these neighboring countries is likely the reason for thepresence of the H genogroup amongst MDR isolates in the study
population.
BCG is part of the universal vaccination in Pakistan. The fact that
59% of patients had no evidence of a vaccination scar is concerning;
a focusing of vaccination systems to increase population access is
required. The high unemployment ﬁgures among TB patients
identiﬁed in this study highlight the need to integrate economic
opportunities into TB control programs.
In summary, while the study is consistent with earlier estimates
of MDR-TB, it further suggests that methodologies relying on RIF
resistance as a marker to detect MDR-TB are likely to be successful.
A greater focus on individuals identiﬁed to be at risk of drug-
resistant TB (including patients with H genogroup) is required.
Finally, based on this initial report of the community-based INH
resistance rate, a review of treatment and prophylaxis regimens
relying on INH in this population is suggested.
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